1. Home
  2. ATCH vs DARE Comparison

ATCH vs DARE Comparison

Compare ATCH & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.19

Market Cap

34.5M

Sector

N/A

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.08

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
DARE
Founded
2022
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
33.4M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
ATCH
DARE
Price
$0.19
$2.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$1.00
$10.00
AVG Volume (30 Days)
1.4M
186.6K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
N/A
$2,807,885.00
Revenue This Year
$84.47
$2,115.12
Revenue Next Year
$39.32
$122.62
P/E Ratio
$4.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$1.27
52 Week High
$1.92
$9.19

Technical Indicators

Market Signals
Indicator
ATCH
DARE
Relative Strength Index (RSI) 38.35 47.20
Support Level $0.19 $1.94
Resistance Level $0.21 $2.23
Average True Range (ATR) 0.01 0.16
MACD -0.00 0.01
Stochastic Oscillator 15.74 59.04

Price Performance

Historical Comparison
ATCH
DARE

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: